| Symbol |
Name |
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABL2
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACKR4
|
atypical chemokine receptor 4
|
|
ACTR2
|
ARP2 actin-related protein 2 homolog (yeast)
|
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast)
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ARF1
|
ADP-ribosylation factor 1
|
|
ARHGAP32
|
Rho GTPase activating protein 32
|
|
ARRB2
|
arrestin, beta 2
|
|
ATAT1
|
alpha tubulin acetyltransferase 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BSG
|
basigin (Ok blood group)
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCL8
|
chemokine (C-C motif) ligand 8
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR10
|
chemokine (C-C motif) receptor 10
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD38
|
CD38 molecule
|
|
CD72
|
CD72 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD9
|
CD9 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
CORO1B
|
coronin, actin binding protein, 1B
|
|
CORO1C
|
coronin, actin binding protein, 1C
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL17
|
chemokine (C-X-C motif) ligand 17
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DAPK2
|
death-associated protein kinase 2
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEFB4A
|
defensin, beta 4A
|
|
DOCK2
|
dedicator of cytokinesis 2
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
ECSCR
|
endothelial cell surface expressed chemotaxis and apoptosis regulator
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ENG
|
endoglin
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAS
|
Fas cell surface death receptor
|
|
FES
|
FES proto-oncogene, tyrosine kinase
|
|
FGF16
|
fibroblast growth factor 16
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FLNA
|
filamin A, alpha
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOSL2
|
FOS-like antigen 2
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
GAS6
|
growth arrest-specific 6
|
|
GBF1
|
golgi brefeldin A resistant guanine nucleotide exchange factor 1
|
|
GEM
|
GTP binding protein overexpressed in skeletal muscle
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNLY
|
granulysin
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GORAB
|
golgin, RAB6-interacting
|
|
GPR132
|
G protein-coupled receptor 132
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HDAC6
|
histone deacetylase 6
|
|
HEBP1
|
heme binding protein 1
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17RC
|
interleukin 17 receptor C
|
|
IL18
|
interleukin 18
|
|
IL2
|
interleukin 2
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
INHBA
|
inhibin, beta A
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB4
|
integrin, beta 4
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JCHAIN
|
joining chain of multimeric IgA and IgM
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
LASP1
|
LIM and SH3 protein 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LEP
|
leptin
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPAR2
|
lysophosphatidic acid receptor 2
|
|
LSP1
|
lymphocyte-specific protein 1
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LTB4R2
|
leukotriene B4 receptor 2
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR31
|
microRNA 31
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP25
|
matrix metallopeptidase 25
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPRIP
|
myosin phosphatase Rho interacting protein
|
|
MTDH
|
metadherin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOTCH1
|
notch 1
|
|
NOV
|
nephroblastoma overexpressed
|
|
NOX4
|
NADPH oxidase 4
|
|
NPS
|
neuropeptide S
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
OR1D2
|
olfactory receptor, family 1, subfamily D, member 2
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RY2
|
purinergic receptor P2Y, G-protein coupled, 2
|
|
PARD3
|
par-3 family cell polarity regulator
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PF4
|
platelet factor 4
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIP5K1B
|
phosphatidylinositol-4-phosphate 5-kinase, type I, beta
|
|
PIP5K1C
|
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLD2
|
phospholipase D2
|
|
PLEKHG2
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 2
|
|
PLG
|
plasminogen
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPIB
|
peptidylprolyl isomerase B (cyclophilin B)
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PSD
|
pleckstrin and Sec7 domain containing
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGDR2
|
prostaglandin D2 receptor 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTX3
|
pentraxin 3, long
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3
|
|
RGMA
|
repulsive guidance molecule family member a
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RHOA
|
ras homolog family member A
|
|
RHOB
|
ras homolog family member B
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
SDC1
|
syndecan 1
|
|
SDC4
|
syndecan 4
|
|
SELE
|
selectin E
|
|
SELPLG
|
selectin P ligand
|
|
SEMA7A
|
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group)
|
|
SGPP1
|
sphingosine-1-phosphate phosphatase 1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SNRNP35
|
small nuclear ribonucleoprotein 35kDa (U11/U12)
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STK11
|
serine/threonine kinase 11
|
|
TBX21
|
T-box 21
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFF2
|
trefoil factor 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TREM2
|
triggering receptor expressed on myeloid cells 2
|
|
TRIP10
|
thyroid hormone receptor interactor 10
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TXN
|
thioredoxin
|
|
TYROBP
|
TYRO protein tyrosine kinase binding protein
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAN
|
versican
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
VN1R17P
|
vomeronasal 1 receptor 17 pseudogene
|
|
VTN
|
vitronectin
|
|
WAS
|
Wiskott-Aldrich syndrome
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
XCR1
|
chemokine (C motif) receptor 1
|